Return to study ST002999 main page

Download data matrix(Metabolomics and glucose and glutamine labeled isotope tracing analysis in murine lung adenocarcinoma cells in the context of normal or active NRF2 pathway as well as HDAC and glutaminase inhibitor treatment. HILIC NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
HILIC NEGATIVE ION MODEEV_CB839_Gln_1Genotype:Empty vector | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_CB839_Gln_2Genotype:Empty vector | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_CB839_Gln_3Genotype:Empty vector | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_1h_1Genotype:Empty vector | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_1h_2Genotype:Empty vector | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_1h_3Genotype:Empty vector | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_24h_1Genotype:Empty vector | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_24h_2Genotype:Empty vector | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_24h_3Genotype:Empty vector | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_Gln_1Genotype:Empty vector | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_Gln_2Genotype:Empty vector | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_DMSO_Gln_3Genotype:Empty vector | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_1h_1Genotype:Empty vector | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_1h_2Genotype:Empty vector | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_1h_3Genotype:Empty vector | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_24h_1Genotype:Empty vector | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_24h_2Genotype:Empty vector | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_Rom_24h_3Genotype:Empty vector | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_ROM_Gln_1Genotype:Empty vector | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_ROM_Gln_2Genotype:Empty vector | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODEEV_ROM_Gln_3Genotype:Empty vector | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_CB839_Gln_1Genotype:NRF2 overexpression | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_CB839_Gln_2Genotype:NRF2 overexpression | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_CB839_Gln_3Genotype:NRF2 overexpression | Treatment:CB-839 | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_1h_1Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_1h_2Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_1h_3Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_24h_1Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_24h_2Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_24h_3Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_Gln_1Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_Gln_2Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_DMSO_Gln_3Genotype:NRF2 overexpression | Treatment:DMSO | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_1h_1Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_1h_2Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_1h_3Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:1 hour | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_24h_1Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_24h_2Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_Rom_24h_3Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:24 hours | Tracer:U-C13 GlucoseAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_ROM_Gln_1Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_ROM_Gln_2Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
HILIC NEGATIVE ION MODENRF2_ROM_Gln_3Genotype:NRF2 overexpression | Treatment:Romidepsin | Timepoint:8 hours | Tracer:U-C13 GlutamineAbundance (Extracted ion chromatogram core area)
  logo